The pharmaceutical industry’s biggest lobbying group is scheduled to meet with President Donald Trump on Thursday, according ...

(Reuters) - U.S. President Donald Trump will meet on Thursday with chief executives from major drugmakers, a White House ...

Manufacturers of medicines, including Pfizer and Eli Lilly, have spent a combined $450,000 lobbying against price caps on ...

As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...

President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.

U.S. President Donald Trump is set to meet with top pharmaceutical executives on Thursday, a White House official confirmed.

The Trump administration, perhaps surprisingly, chose to defend the legality of the Inflation Reduction Act’s (IRA’s) drug ...

Trump previously met with Ubl and chief executives of U.S. drugmakers Pfizer and Eli Lilly at his Mar-a-Lago estate in Florida in December.

America's pharmaceutical founding fathers ... a new era for the way the pharmaceutical industry developed drugs. The war had also encouraged research into everything from new analgesics to drugs ...

The industry is on a strong growth trajectory, with experts predicting notable achievements over the next decade. Forecasts ...